EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Opioid‐Associated Hippocampal Injury: Past, Present, and Future Directions

Jed A Barash iD, Joshua Madden, W Andrew Kofke

Hippocampus · 2026-07 · 36 (4)

DOI: 10.1002/hipo.70111 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hippocampus, online erschienen am 22.06.2026. Verfasst von Jed A Barash und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Massachusetts Veterans Home at Chelsea, Chelsea, Massachusetts, USA. Hauptthemen laut MEDLINE: Hippocampus, Analgesics, Opioid, Opioid-Related Disorders. Die Arbeit nennt 127 Literaturangaben. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Three of the great public health challenges of our time converge at the hippocampus. The first, dementia, most commonly in the form of Alzheimer's disease, is well known to cause progressive hippocampal damage, resulting in the memory loss associated with the illness. The second, COVID‐19 infection, has thus far been linked to hippocampal alterations across multiple studies. Lastly, the third, opioids—especially in the setting of misuse—have been associated with acute and persistent hippocampal injury; this review focuses on the collection of pre‐clinical, clinical, and epidemiologic observations supporting this final relationship. Basic science work dating back decades has demonstrated a hypermetabolic response to opioids and associated damage to the hippocampus. The earliest cases recognized as opioid‐associated amnestic syndrome (OAS) were subsequently identified in 2012 and reported as part of larger case series several years later. In 2019, a related but more fulminant syndrome involving cerebellar, hippocampal, and basal nuclei transient edema with restricted diffusion (CHANTER) was first described. From these investigations, a growing body of data has since emerged to suggest that regular opioid use, particularly at higher doses or potency, may be connected to a reduction in hippocampal volume and greater risk of dementia. This review begins with a synthesis of data supporting the underlying pathological mechanisms of opioid‐associated hippocampal injury (OAHI), then covers the clinical spectrum of this phenomenon. Lastly, we will close with implications of OAHI that warrant further study, including the future epidemiologic impact on related cognitive disorders in the wake of the opioid epidemic and potential therapeutic applications of opioid antagonism for mild cognitive impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HippocampusAnalgesics, OpioidOpioid-Related DisordersHumansAnimalsAmnesia

Stichwörter der Autor:innen

amnesiafentanylhippocampusinjuryopioid

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Department of Medicine, Massachusetts Veterans Home at Chelsea, Chelsea, Massachusetts, USA.
  • Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Jed A Barash

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

Barash, J. A., Madden, J., & Kofke, W. A. (2026). Opioid‐Associated Hippocampal Injury: Past, Present, and Future Directions. Hippocampus, 36(4). https://doi.org/10.1002/hipo.70111

Vancouver

Barash JA, Madden J, Kofke WA. Opioid‐Associated Hippocampal Injury: Past, Present, and Future Directions. Hippocampus. 2026;36(4). doi:10.1002/hipo.70111

BibTeX
@article{Barash2026,
  author = {Barash, Jed A and Madden, Joshua and Kofke, W Andrew},
  title = {Opioid‐Associated Hippocampal Injury: Past, Present, and Future Directions},
  journal = {Hippocampus},
  year = {2026},
  volume = {36},
  number = {4},
  doi = {10.1002/hipo.70111}
}
Kostenlos starten →